fluticasone + umeclidinium + vilanterol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for fluticasone + umeclidinium + vilanterol, covering 2023-11-13 to 2023-11-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol